LEN monotherapy (n = 39) | LEN combination (n = 72) | LEN + PD1 (n = 30) | LEN + HAIF/TACE (n = 24) | LEN + PD1 + HAIF/TACE (n = 16) | |
---|---|---|---|---|---|
CR | 0 | 2/3% | 1/3% | 0 | 0 |
PR | 6/15% | 19/26% | 10/33% | 7/29% | 2/13% |
SD | 21/54% | 42/58% | 12/40% | 17/71% | 12/75% |
ORR | 15% | 29% | 36% | 29% | 13% |
DCR | 69% | 87% | 76% | 100% | 88% |